Clinical trial
A Safety and Efficacy Trial Evaluating the Use of Fondaparinux in Percutaneous…
NCT00060554 · Schering-Plough, Industry · Withdrawn
Key facts
| NCT number | NCT00060554 |
|---|---|
| Title | A Safety and Efficacy Trial Evaluating the Use of Fondaparinux in Percutaneous Coronary Intervention (PCI)(63133)(WITHDRAWN) |
| Lead sponsor | Schering-Plough, Industry |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Myocardial Infarction, Coronary Disease |
| Intervention type | Drug, Procedure |
| Interventions | fondaparinux sodium, heparin, percutaneous coronary intervention (PCI) |
| Enrollment | 300 |
| Start date | Apr 1, 2003 |
| First posted | May 8, 2003 |
| Last update posted | Nov 3, 2009 |
| Countries | Canada, France, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: